Envestnet Portfolio Solutions
JAZZ icon

Envestnet Portfolio Solutions’s Jazz Pharmaceuticals JAZZ Stock Holding History

Envestnet Portfolio Solutions’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Sell
8,030
-2,258
-22% -$495K 0.01% 503
2026
Q1 		$1.94M Sell
10,288
-1,266
-11% -$221K 0.01% 467
2025
Q4 		$1.96M Buy
11,554
+369
+3% +$56.6K 0.01% 551
2025
Q3 		$1.47M Sell
11,185
-649
-5% -$77.8K 0.01% 613
2025
Q2 		$1.26M Buy
11,834
+7,465
+171% +$811K ﹤0.01% 710
2025
Q1 		$542K Buy
4,369
+1,223
+39% +$160K ﹤0.01% 1014
2024
Q4 		$387K Buy
3,146
+502
+19% +$59.2K ﹤0.01% 1362
2024
Q3 		$295K Sell
2,644
-109
-4% -$11.9K ﹤0.01% 1463
2024
Q2 		$294K Buy
2,753
+335
+14% +$36.8K ﹤0.01% 1388
2024
Q1 		$291K Buy
2,418
+353
+17% +$43.2K ﹤0.01% 1377
2023
Q4 		$254K Sell
2,065
-549
-21% -$68.5K ﹤0.01% 1380
2023
Q3 		$338K Buy
+2,614
New +$348K ﹤0.01% 1167

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Envestnet Portfolio Solutions's JAZZ Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its Jazz Pharmaceuticals (JAZZ) stake by 22% in Q2 2026, selling an estimated $495K and leaving 8,030 shares worth $1.93M. The position accounts for 0.01% of the portfolio, ranked #503.

Envestnet Portfolio Solutions first reported a position in JAZZ in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.96M in Q4 2025. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Envestnet Portfolio Solutions held 8,030 shares of Jazz Pharmaceuticals worth $1.93M as of Q2 2026.
  • Envestnet Portfolio Solutions sold 2,258 Jazz Pharmaceuticals shares in Q2 2026, an estimated $495K.
  • Jazz Pharmaceuticals made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #503 holding.
  • Envestnet Portfolio Solutions first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Jazz Pharmaceuticals position peaked at $1.96M in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.